CarboGen

CarboGen and AMCIS are recognized as global leaders in the development of the chemical market, integrating world-class chemical technology to provide seamless drug development and commercialization services. As world leaders in chemical development, they are committed to science, speed, and quality. In 2003-2004, they served more than 60 pharmaceutical companies, including seven of the top ten global firms. Currently, over 60% of their revenue comes from the United States. Their work helps clients make critical decisions more efficiently and accelerates the progress of candidate drugs through the development pipeline.